NCT06594874 A Phase Ib Study of HS-10370 in Addition to Other Anti-cancer Therapies in Participants with KRAS G12C Mutation Advanced Solid Tumors Status NOT_YET_RECRUITING Phase PHASE1
NCT06556108 ALPP CAR-T Cells for ALPP-Positive Advanced Solid Tumors Status COMPLETED Phase PHASE1/PHASE2
NCT06555744 A Study of ZW191 in Participants With Solid Tumors Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT06547957 A First-in-Human Study of EOS301984 as Monotherapy or Combination Therapy in Adult Participants With Advanced Solid Tumors Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT06544655 A Study of BMS-986484 Alone and Combination Therapy in Participants With Advanced Solid Tumors Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT06532565 Study of GS-2121 Given Alone or in Combination in Adults With Advanced Solid Tumors Status RECRUITING Phase PHASE1
NCT06520488 A Study of HRS-4642 in Combination With Antineoplastic Agents in Advanced Solid Tumors Status RECRUITING Phase PHASE1/PHASE2
NCT06500676 A Study of GFH375 in Patients With Advanced Solid Tumors With KRAS G12D Mutations Status RECRUITING Phase PHASE1/PHASE2
NCT06480552 An Open-label Dose Escalation/Expansion Trial to Evaluate the Safety and Anti-tumor Activity of TEV-56278 Alone or in Combination With Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors Status RECRUITING Phase PHASE1
NCT06474455 A Phase IB/II Clinical Study of SHR-9839 for Injection Combined With Other Anti-tumor Therapies in Patients With Advanced Solid Tumors Status RECRUITING Phase PHASE1/PHASE2
NCT06459973 A Clinical Study of YL205 in Patients With Advanced Solid Tumors Status RECRUITING Phase PHASE1/PHASE2
NCT06445517 Study Evaluating ISM8207 in Participants With Advanced Solid Tumors and Relapsed/Refractory B-Cell Lymphoma Status RECRUITING Phase PHASE1
NCT06439589 Phase Ib/II Study of HRS2398 in Combination With Adebrelimab in Patients With Advanced Solid Tumors Status RECRUITING Phase PHASE1/PHASE2
NCT06417554 A Trial of SHR-A2102 With or Without Antitumor Therapy in Advanced Solid Tumors Status RECRUITING Phase PHASE1/PHASE2
NCT06413680 A First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works in Adult Participants Who Have Cancer With Tumors That Have Spread in Their Body Status RECRUITING Phase PHASE1/PHASE2
NCT06394414 A Phase 1 Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of YL201 in Advanced Solid Tumors Status RECRUITING Phase PHASE1
NCT06384352 A Phase I Study to Evaluate the Safety,Tolerability, Pharmacokinetics, and Efficacy of YL211 in Patients With Advanced Solid Tumors Status RECRUITING Phase PHASE1